Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Gastroenterology

Does NF1 Cause Gastrointestinal Issues and GISTs?

At a Glance

Adults with Neurofibromatosis type 1 (NF1) have an increased risk of developing digestive tract tumors, including Gastrointestinal Stromal Tumors (GISTs). Since routine scans aren't standard without symptoms, patients should monitor for warning signs like unexplained abdominal pain, dark stools, or anemia.

In this answer

3 sections

01

Gastrointestinal Stromal Tumors (GISTs)

02

Neuroendocrine Tumors

03

Warning Signs to Watch For

Yes, adults with Neurofibromatosis type 1 (NF1) can experience specific stomach and digestive issues. While you might be familiar with the typical benign (noncancerous) nerve and skin tumors of NF1, the condition also increases the risk of developing internal digestive tract tumors that can sometimes behave like cancer or become malignant. These include Gastrointestinal Stromal Tumors (GISTs) and certain neuroendocrine tumors [1]. Learning that you are at risk for internal tumors can be scary, but because routine imaging (like CT or MRI scans) is not standard for people who feel perfectly well, knowing what warning signs require immediate investigation puts the power back in your hands [2].

Gastrointestinal Stromal Tumors (GISTs)

Gastrointestinal Stromal Tumors (GISTs) are tumors of the digestive tract that occur significantly more often in individuals with NF1 than in the general population [1].

GISTs in people with NF1 tend to behave differently than they do in people without the condition:

  • Location: They typically develop in the small intestine (such as the duodenum or jejunum) rather than in the stomach [3][4].
  • Multiple tumors: They frequently occur in multiple locations at the same time, a pattern known as multifocal disease [5][3].
  • Age of onset: They often appear at a younger age than sporadic GISTs (those that happen outside of a genetic syndrome) [3][4].
  • Genetics and treatment: NF1-associated GISTs often lack the typical genetic mutations seen in sporadic GISTs [5][6]. Because of this, standard targeted medications used for sporadic GISTs are typically reserved only for high-risk cases, and surgical removal is often the primary treatment [7][1].

Neuroendocrine Tumors

People with NF1 also have a higher risk of developing neuroendocrine tumors, which grow from cells that typically release hormones [8].

A specific type of neuroendocrine tumor called a somatostatinoma can form in the upper part of the small intestine or near the bile ducts [9]. While some of these tumors produce symptoms like diarrhea, in NF1 they frequently cause issues by physically blocking the intestines or bile ducts [8][9]. Finding both a neuroendocrine tumor and a GIST in the same person is a very strong indicator of NF1 [10][11].

Additionally, NF1 is associated with a higher risk for pheochromocytomas (rare tumors of the adrenal gland that release adrenaline), which can sometimes occur alongside digestive tumors and cause sudden spikes in blood pressure [11][12].

Warning Signs to Watch For

Because current guidelines generally do not recommend routine systematic abdominal scans for NF1 patients who have no symptoms, monitoring your own health is your most important tool [13][2]. If you develop any of the following, you should contact your NF specialist or a gastroenterologist for an immediate evaluation:

  • Unexplained abdominal pain [14].
  • Gastrointestinal bleeding, which might appear as black, tarry stools (melena) or bright red blood [4][14].
  • Anemia (a low red blood cell count caused by slow bleeding), which can make you feel unusually tired, weak, or short of breath [4][15].
  • Signs of an intestinal blockage (obstruction), such as severe cramps, nausea, vomiting, or an inability to pass gas [14].
  • Jaundice, a yellowing of the skin or eyes often accompanied by dark urine, which can happen if a tumor blocks the bile ducts [9].

When these symptoms occur, your care team should promptly investigate using imaging or an endoscopy (using a camera to look inside the digestive tract) [2].

Common questions in this guide

Does NF1 cause stomach and digestive issues?
Yes, adults with NF1 can experience specific digestive issues. The condition increases the risk of developing internal digestive tract tumors, including Gastrointestinal Stromal Tumors (GISTs) and certain neuroendocrine tumors.
How are GISTs different in people with NF1?
In NF1, GISTs typically develop in the small intestine rather than the stomach and frequently occur in multiple locations. They also tend to appear at a younger age and often lack the genetic mutations seen in sporadic GISTs.
What are the warning signs of a GI tumor in NF1?
Warning signs include unexplained abdominal pain, signs of gastrointestinal bleeding like black or tarry stools, and unexplained anemia causing fatigue. You should also be alert for signs of an intestinal blockage or jaundice.
Should I get routine abdominal scans to check for tumors if I have NF1?
Current guidelines generally do not recommend routine abdominal scans for NF1 patients who have no symptoms. Instead, monitoring your own health and contacting your doctor immediately if you develop warning signs is the most effective approach.
How are NF1-related GISTs usually treated?
Because NF1-associated GISTs often lack the typical genetic mutations seen in sporadic GISTs, standard targeted medications are usually reserved for high-risk cases. Surgical removal is often the primary treatment for these tumors.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should I be checking for anemia during my routine annual blood work to monitor for slow bleeding?
  2. 2.If I develop unexplained abdominal pain, what specific imaging tests should we prioritize to check for GISTs or neuroendocrine tumors?
  3. 3.Are you familiar with the specific ways GISTs present and are treated in NF1 compared to the general population?
  4. 4.Should I establish care with a gastroenterologist now, or wait until I have symptoms?
  5. 5.Do I need regular blood or urine tests to screen for pheochromocytomas?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Genetic Testing Predict How Severe NF1 Will Be?Do Café-Au-Lait Spots Mean My Baby Has NF1?Do Cutaneous Neurofibromas Turn Into Cancer?Do Neurofibromas Grow Back After Surgical Removal?How to Find an NF1 Specialist for AdultsMild NF1 Symptoms: Can You Have Them Your Whole Life?Does NF1 Affect Life Expectancy? Facts & OutcomesWhat Are the Newest MEK Inhibitors for NF1?Does Neurofibromatosis (NF1) Cause High Blood Pressure?When Should Women With NF1 Start Breast Cancer Screening?Can Diet and Supplements Stop NF1 Tumor Growth?Will I Pass on NF1 If I'm the First in My Family?Does NF1 Cause Learning and Behavioral Issues?What Are the MPNST Warning Signs in NF1 Tumors?How to Screen for Optic Pathway Gliomas in NF1?What Are Selumetinib (Koselugo) Side Effects in NF1?How to Transition From Pediatric to Adult NF1 CareDo Asymptomatic NF1 Patients Need a Whole-Body MRI?Why is Radiation Avoided for NF1 Tumors?

References

References (15)
  1. 1

    Unusual presentation of GIST associated with type 1 neurofibromatosis: A case report.

    Girma T, Nureta TH, Abebe DM

    International journal of surgery case reports 2023; (105()):107992 doi:10.1016/j.ijscr.2023.107992.

    PMID: 36940542
  2. 2

    Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1.

    Dupuis H, Chevalier B, Cardot-Bauters C, et al.

    Journal of the Endocrine Society 2023; (7(8)):bvad083 doi:10.1210/jendso/bvad083.

    PMID: 37409183
  3. 3

    GIST associated with von recklinghausen disease: Report of two cases and review of literature.

    Vargas Ávila AL, Jiménez Leyva A, Vargas Flores J, et al.

    Annals of medicine and surgery (2012) 2021; (62()):365-368 doi:10.1016/j.amsu.2021.01.033.

    PMID: 33552495
  4. 4

    A Rare Association Between Gastrointestinal Stromal Tumor and Neurofibromatosis Type 1: A Case Report.

    Abu-Abaa M, Abdulsahib A, Kananeh S, Aldookhi A

    Cureus 2023; (15(1)):e34148 doi:10.7759/cureus.34148.

    PMID: 36843795
  5. 5

    Hidden in the mesentery - surgical management of bleeding gastrointestinal stromal tumor in neurofibromatosis type I.

    Škrabal M, Vidim T, Veškrňa K

    Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti 2026; (105(3)):134-141 doi:10.48095/ccrvch2026134.

    PMID: 42045002
  6. 6

    Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

    Gasparotto D, Rossi S, Polano M, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2017; (23(1)):273-282 doi:10.1158/1078-0432.CCR-16-0152.

    PMID: 27390349
  7. 7

    Gastrointestinal stromal tumor in patient with neurofibromatosis type 1: A case report.

    Ibrahimi A, Lachkar S, Boualaoui I, et al.

    International journal of surgery case reports 2025; (129()):111166 doi:10.1016/j.ijscr.2025.111166.

    PMID: 40106943
  8. 8

    The Coexistence of Somatostatinoma and Gastrointestinal Stromal Tumor in the Duodenum of a Patient with Von Recklinghausen's Disease.

    Yamamoto R, Kato S, Maru T, et al.

    Internal medicine (Tokyo, Japan) 2016; (55(6)):617-22 doi:10.2169/internalmedicine.55.5761.

    PMID: 26984078
  9. 9

    [Neuroendocrine Tumor of the Ampulla of Vater and Gastrointestinal Stromal Tumor of the Duodenum in a Patient with Von Recklinghausen's Disease].

    Yamada Y, Shiozawa S, Usui T, et al.

    Gan to kagaku ryoho. Cancer & chemotherapy 2016; (43(12)):2365-2367.

    PMID: 28133323
  10. 10

    Concomitant neuroendocrine tumor and gastrointestinal stromal tumor in a duodenal fine needle aspiration: A cytologic clue for neurofibromatosis type 1.

    Tran TAN, Rosales A, Arnoletti JP, et al.

    Diagnostic cytopathology 2021; (49(2)):E45-E48 doi:10.1002/dc.24579.

    PMID: 33280280
  11. 11

    Triple malignancy (NET, GIST and pheochromocytoma) as a first manifestation of neurofibromatosis type-1 in an adult patient.

    Poredska K, Kunovsky L, Prochazka V, et al.

    Diagnostic pathology 2019; (14(1)):77 doi:10.1186/s13000-019-0848-7.

    PMID: 31301733
  12. 12

    An Autopsy Case of Sudden Death in Neurofibromatosis Type 1 With Pheochromocytoma and Myocarditis.

    Takamiya M, Niitsu H, Saigusa K

    The American journal of forensic medicine and pathology 2018; (39(1)):78-81 doi:10.1097/PAF.0000000000000367.

    PMID: 29210711
  13. 13

    Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1.

    Moramarco J, El Ghorayeb N, Dumas N, et al.

    Clinical endocrinology 2017; (86(3)):332-339 doi:10.1111/cen.13265.

    PMID: 27787920
  14. 14

    Reminder for the clinician: abdominal manifestations of type 1 neurofibromatosis are not so uncommon.

    Portale G, Rulli R, Spolverato YC, Mascellino P

    BMJ case reports 2022; (15(8)) doi:10.1136/bcr-2022-250951.

    PMID: 35918081
  15. 15

    The Bleeding Bowel: A Rare Case of Neurofibromatosis Type 1-associated Gastrointestinal Stromal Tumor in a Young Male.

    Kalayanamitra R, Shahid Z, Shah N, et al.

    Cureus 2019; (11(6)):e4868 doi:10.7759/cureus.4868.

    PMID: 31417813

This page provides educational information about gastrointestinal risks associated with NF1. It is not medical advice; always consult your NF specialist or gastroenterologist for the evaluation of any digestive symptoms.

Get notified when new evidence is published on Neurofibromatosis type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.